Idiopathic pulmonary fibrosis: an update on pathogenesis

Q Mei, Z Liu, H Zuo, Z Yang, J Qu - Frontiers in pharmacology, 2022‏ - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a progressive, lethal fibrotic lung disease that occurs
primarily in middle-aged and elderly adults. It is a major cause of morbidity and mortality …

At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy

N Vasan, LC Cantley - Nature Reviews Clinical Oncology, 2022‏ - nature.com
Numerous agents targeting various phosphatidylinositol 3-kinase (PI3K) pathway
components, including PI3K, AKT and mTOR, have been tested in oncology clinical trials …

[HTML][HTML] Myofibroblasts: function, formation, and scope of molecular therapies for skin fibrosis

Y Tai, EL Woods, J Dally, D Kong, R Steadman… - Biomolecules, 2021‏ - mdpi.com
Myofibroblasts are contractile, α-smooth muscle actin-positive cells with multiple roles in
pathophysiological processes. Myofibroblasts mediate wound contractions, but their …

Emerging role of immune cells as drivers of pulmonary fibrosis

SE Mutsaers, T Miles, CM Prêle, GF Hoyne - Pharmacology & Therapeutics, 2023‏ - Elsevier
The pathogenesis of pulmonary fibrosis, including idiopathic pulmonary fibrosis (IPF) and
other forms of interstitial lung disease, involves a complex interplay of various factors …

TGF-β1: Gentlemanly orchestrator in idiopathic pulmonary fibrosis

Z Ye, Y Hu - International journal of molecular …, 2021‏ - spandidos-publications.com
Idiopathic pulmonary fibrosis (IPF) is a worldwide disease characterized by the chronic and
irreversible decline of lung function. Currently, there is no drug to successfully treat the …

Fasting renders immunotherapy effective against low-immunogenic breast cancer while reducing side effects

S Cortellino, A Raveane, C Chiodoni, G Delfanti… - Cell reports, 2022‏ - cell.com
Immunotherapy is improving the prognosis and survival of cancer patients, but despite
encouraging outcomes in different cancers, the majority of tumors are resistant to it, and the …

The role of macrophage polarization and cellular crosstalk in the pulmonary fibrotic microenvironment: a review

B Zhou, H Liu, F Xu, X Jia - Cell Communication and Signaling, 2024‏ - Springer
Pulmonary fibrosis (PF) is a progressive interstitial inflammatory disease with a high
mortality rate. Patients with PF commonly experience a chronic dry cough and progressive …

Fibroblast heterogeneity: Keystone of tissue homeostasis and pathology in inflammation and ageing

V Gauthier, M Kyriazi, M Nefla, V Pucino… - Frontiers in …, 2023‏ - frontiersin.org
Fibroblasts, derived from the embryonic mesenchyme, are a diverse array of cells with roles
in development, homeostasis, repair, and disease across tissues. In doing so, fibroblasts …

[HTML][HTML] Metabolites and immune response in tumor microenvironments

S Cortellino, VD Longo - Cancers, 2023‏ - mdpi.com
Simple Summary Cancer cells alter their metabolisms to support growth, thus causing micro-
and macronutrient changes in the metabolite profile that promote an immunosuppressive …

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β

AP Jiménez-Uribe, T Gómez-Sierra, OE Aparicio-Trejo… - Cellular …, 2021‏ - Elsevier
The fibrotic process could be easily defined as a pathological excess of extracellular matrix
deposition, leading to disruption of tissue architecture and eventually loss of function; …